Related Experiment Video

Updated: May 30, 2026

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm
08:12

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm

Published on: December 22, 2016

JAK-mutant myeloproliferative neoplasms

Ross L Levine1

  • 1Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA. leviner@mskcc.org

Current Topics in Microbiology and Immunology
|August 9, 2011
PubMed

Insights

Janus kinase (JAK) activation, particularly JAK2V617F mutations, is key in myeloproliferative neoplasms (MPN) and other cancers. Research is exploring JAK inhibitors for treating these malignancies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Signal Transduction

Background:

  • The Janus kinase (JAK) family, including JAK1, JAK2, JAK3, and TYK2, plays a crucial role in cellular signaling.
  • Recent discoveries highlight the significance of JAK activation in human malignancies, particularly BCR-ABL-negative myeloproliferative neoplasms (MPN).

Purpose of the Study:

  • To review genetic alterations activating JAK signaling in various cancers.
  • To discuss the development of small-molecule JAK inhibitors for cancer therapy.

Main Methods:

  • Literature review of studies identifying genetic alterations in JAK signaling pathways.
  • Analysis of research on small-molecule inhibitors targeting JAK kinase activity.

Main Results:

  • A recurrent JAK2V617F mutation is found in most patients with MPN, polycythemia vera, essential thrombocytosis, and primary myelofibrosis.
  • Other JAK-STAT pathway-activating mutations identified in MPN and leukemia subsets.
  • Dysregulated JAK-STAT signaling implicated in epithelial neoplasms.

Conclusions:

  • Genetic alterations activating JAK signaling are implicated in diverse malignancies.
  • Small-molecule JAK inhibitors represent a promising therapeutic strategy for MPNs and other cancers.

More Related Videos

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...